Sanofi India to host earnings call on August 5, 2026

1 min read     Updated on 23 Jul 2026, 11:38 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Sanofi India Limited announced an investor call for August 5, 2026, to review unaudited results for the quarter and half year ended June 30, 2026. The session runs from 4:00 p.m. to 5:00 p.m. IST, requiring pre-registration by 12:00 p.m. on the same day. Domestic and international dial-in facilities are available.

powered bylight_fuzz_icon
46332504

*this image is generated using AI for illustrative purposes only.

sanofi India Limited has announced it will host an investor and analyst conference call to provide an update on its unaudited financial results for the quarter and half year ended June 30, 2026. The meeting is scheduled for August 5, 2026, from 4:00 p.m. to 5:00 p.m. IST, allowing stakeholders to engage with the company's management regarding its recent financial performance.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has facilitated access through various dial-in numbers for domestic and international participants, alongside a webcast option for those unable to join via phone.

Conference Call Details

The following table outlines the specific logistics for the upcoming earnings call:

Parameter Details
Date Wednesday, August 5, 2026
Time 4:00 p.m. to 5:00 p.m. IST
Universal Dial-in +91 22 6280 1191, +91 22 7115 8075
Webcast Available via company link

Participation Guidelines

Investors wishing to participate in the question-and-answer session must pre-register for the event. Registration will remain open until 12:00 p.m. IST on August 5, 2026. The company has noted that participants will have the opportunity to view the presentation and ask questions to the management in the sequence of their registration.

International participants can access the call via toll-free numbers designated for specific regions, including the USA, UK, Australia, Japan, and several European and Asian countries. A one-way audio webcast will also be hosted for broader accessibility.

Historical Stock Returns for Sanofi

1 Day5 Days1 Month6 Months1 Year5 Years
-0.32%+0.64%+1.65%-16.20%-42.49%-57.56%

What strategic initiatives is Sanofi India pursuing to drive growth in the second half of fiscal 2026?

How might the unaudited results influence investor sentiment ahead of the full-year earnings release?

What are the expected market reactions to any significant deviations from the previous year's performance?

Sanofi India CFO Rachid Ayari Resigns Effective September 30, 2026

1 min read     Updated on 23 Jul 2026, 10:52 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Sanofi India Limited announced the resignation of Rachid Ayari (DIN: 10408699) as Whole Time Director, CFO, and Key Managerial Personnel, effective September 30, 2026, as he transitions to another role within the Sanofi group. The company is in the process of identifying a suitable replacement CFO and will notify stock exchanges upon appointment.

powered bylight_fuzz_icon
46205664

*this image is generated using AI for illustrative purposes only.

Sanofi India Limited disclosed the resignation of Mr. Rachid Ayari as Whole Time Director, Chief Financial Officer, and Key Managerial Personnel, effective from the close of business hours on September 30, 2026. The resignation follows his decision to transition to another role within the Sanofi group. Consequently, Mr. Ayari will also cease to be a member of the Risk Management Committee and Senior Management Personnel on the same date.

The company acknowledged Mr. Ayari's contributions, noting his valuable guidance and dedicated assistance during his tenure. Sanofi India is currently in the process of identifying a suitable candidate for the position of Chief Financial Officer, who will also be designated as Key Managerial Personnel. The stock exchanges will be informed of the appointment in due course.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirmed that there are no other material reasons for the resignation apart from the transition within the group.

Key Details of Resignation

Particulars: Details
Personnel: Rachid Ayari (DIN: 10408699)
Role: Whole Time Director, Chief Financial Officer, Key Managerial Personnel
Effective Date: September 30, 2026
Reason: Transition to another role within the Sanofi group

Historical Stock Returns for Sanofi

1 Day5 Days1 Month6 Months1 Year5 Years
-0.32%+0.64%+1.65%-16.20%-42.49%-57.56%

Who will be appointed as the new CFO to replace Rachid Ayari?

How will the leadership transition impact Sanofi India's financial strategy?

What specific role within the Sanofi group will Rachid Ayari assume?

More News on Sanofi

1 Year Returns:-42.49%